ACH-1625

Invest in the Great Progress of Hepatitis C

Invest in the Great Progress of Hepatitis C

Motley Fool

Does Achillion Have a Place in the HCV Market of the Future?

Does Achillion Have a Place in the HCV Market of the Future?

Yahoo/Reuters

Achillion Back On The Hep C Roller Coaster Of Love

Achillion Back On The Hep C Roller Coaster Of Love

Seeking Alpha

5 Biotech Stocks That Could Soar On New Hepatitis C Drugs

5 Biotech Stocks That Could Soar On New Hepatitis C Drugs

Seeking Alpha

Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C

Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C

Yahoo/Globe NewsWire

Achillion: A Compelling 'Buy' Candidate Now

Achillion: A Compelling 'Buy' Candidate Now

Motley Fool

Watch Achillion Pharmaceutical For Upcoming Phase IIa Data

Watch Achillion Pharmaceutical For Upcoming Phase IIa Data

Forex Pros

Watch Achillion Pharmaceuticals For Upcoming Phase IIa Data

Watch Achillion Pharmaceuticals For Upcoming Phase IIa Data

Seeking Alpha

Achillion's hepatitis C drug gets FDA fast track

Achillion's hepatitis C drug gets FDA fast track

Reuters